The U.S. government has reached a new deal with Moderna for 65 million additional COVID-19 vaccine doses, the Biden administration announced on July 29.
The deal is valued at $1.7 billion.
Moderna will sell doses of its vaccine that target Omicron subvariants, according to the agencies that announced the agreement. The actual contract has not yet been made public.
No comments:
Post a Comment